Product Image

Elite Omega-3 plus D & K Natural Lemon Flavor

4.9
★ ★ ★ ★ ★
(6382 ratings)
Vitamin K 90 mcg
Product Image
Score72
A convenient D3 and MK-7 softgel with appropriate fat-based delivery. Missing EPA and DHA amounts keep the fish oil from adding dependable value.
How scoring works
Softgel
Quantity:60 Softgel(s) • (60 servings)
Goals:
Bone Health
Heart Health
Cardiovascular Support

Score 72

A convenient D3 and MK-7 softgel with appropriate fat-based delivery. Missing EPA and DHA amounts keep the fish oil from adding dependable value.
How scoring works

Also available as

2 options
180 servings K 90 mcg • 180 Softgel(s) • 180 servings $93.50 ($0.51 per serving) 60 servings K 90 mcg • 60 Softgel(s) • 60 servings $48.37 ($0.80 per serving)
$48.37($0.80 per serving)
Vitacost
$ 48.37
iHerb
$ 48.37
Pure Formulas
$ 48.37
iHerb
$ 48.37
Report prices

Analysis

One softgel combines 50 mcg of cholecalciferol, 90 mcg of MK-7, and one gram of Norwegian fish-oil concentrate. The two vitamins are well matched for calcium-regulation and bone nutrient support.

EPA and DHA are not stated, leaving the oil concentration and active cardiovascular dose unknown. The label is clear for D3 and K2 but incomplete for the ingredient that gives the product much of its positioning.

Softgel delivery is convenient and supplies fat for vitamin absorption. It suits users prioritizing D3 and K2, while dedicated omega-3 buyers should select a product with full fatty-acid disclosure.

Who is it for
  • Adults seeking D3 and K2 in one softgel
  • People who value oil-based delivery
  • Users not depending on a known EPA and DHA dose
Best for
  • Combined D3 and K2 support
  • One-softgel bone nutrient use
  • Fat-soluble vitamin delivery

Pros

  • Uses cholecalciferol and MK-7
  • Provides practical vitamin amounts
  • Fish oil supplies a carrier
  • Requires one softgel daily

Cons

  • EPA is not disclosed
  • DHA is not disclosed
  • Oil concentration is unknown
  • Value is weak for incomplete omega-3 data

Warnings

  • Vitamin K2 can oppose warfarin and related vitamin K antagonists.
  • Fish oil makes the product unsuitable for people with a fish allergy.

Nutrient quality

85 Highest impact

Vitamin D3 and menaquinone-7 are useful forms, while the fish oil fatty-acid profile is unspecified. The fish oil total is meaningful, but EPA and DHA amounts cannot be judged.

Ingredient transparency

59 Moderate impact

Vitamin totals and fish oil quantity are clear, but EPA and DHA amounts are absent. Flavoring and other inactive softgel ingredients are not supplied.

Customer satisfaction

74 High impact

The supplied average indicates very strong aggregate satisfaction. No detailed experience reports are available to identify repeated complaints or confirm perceived benefits.

Value for money

71 High impact

The combined formula supports some of the cost, while missing EPA and DHA details weaken quality. Serving value appears limited for the disclosed ingredients.

Report analysis

Goals

Bone Health
Bone Health
Impact
Highest effect
A- Goal FitA Strength of SupportB- CoverageA Formula Quality
Vitamin K · 90 mcgVitamin D · 50 mcg

Vitamin D3 and MK-7 form a strong signaling pair for calcium absorption and placement in bone. Both amounts are clinically aligned, while fish oil adds a secondary inflammatory pathway with less direct bone evidence.

The fish-oil softgel supplies a lipid base that suits both fat-soluble vitamins. MK-7 can oppose warfarin, so users of vitamin K antagonist anticoagulants need consistent intake and prescriber-guided monitoring.

Study evidence
Vitamin K Supportive 78 studies
Heart Health
Heart Health
Impact
Highest effect
A Goal FitC Strength of SupportB CoverageA Formula Quality
Vitamin K · 90 mcgVitamin D · 50 mcg

Fish oil, vitamin D3, and MK-7 address lipid-related, vascular, and calcium-management pathways. The combination is strongly aligned with heart health, but the 1 g fish oil entry does not disclose EPA or DHA amounts.

Vitamin D3 and K2 are supplied at useful amounts, and the oil carrier supports their absorption. People taking warfarin or other vitamin K antagonist medicines should keep vitamin K intake consistent and follow their prescriber’s guidance.

Study evidence
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies
Cardiovascular Support
Cardiovascular Support
Impact
High effect
B+ Goal FitC- Strength of SupportB- CoverageA Formula Quality
Vitamin K · 90 mcgVitamin D · 50 mcgFish Oil · 1 Gram(s)

Fish oil targets lipid and inflammatory pathways, while vitamin D3 and MK-7 support vascular and calcium regulation. The one-gram oil amount is clear, but EPA and DHA are not separately disclosed, so active omega-3 potency cannot be confirmed.

The softgel supplies fat to aid absorption of vitamins D and K, and the combination is logically constructed. MK-7 can counteract warfarin, so people using vitamin K antagonist anticoagulants need consistent intake and clinician-guided monitoring.

Study evidence
Fish Oil Supportive 185 studies
Vitamin K Supportive 40 studies

Ingredients

IngredientAmount per serving
Calories
10 Calorie(s)
Total Fat
1 Gram(s)
Vitamin D (Cholecalciferol)
 50 mcg
Norwegian Fish Oil concentrate
1 Gram(s)
Vitamin K2 (Menaquinone-7)
 90 mcg
Gluten Free Adults 18–50
Report overview
Vitamin K (Menaquinone-7) · 90 mcg OverallScore85
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyD+ Value

MK-7 at a clinically aligned dose is carried in a fish-oil softgel that supports absorption. The source lacks branded or all-trans verification, and the serving cost is elevated despite the added vitamin D and omega-3s. Vitamin K2 can interfere with vitamin K antagonist anticoagulants such as warfarin, so users of those medicines need clinician-guided consistency.

View ingredientView products
Loading alternative details
87 Performance

Vitamin K2 100 mcg

SR Sports Research
<p>The formula provides 100 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Performance

Vitamin K2 MK-7 (Menaquinone-7) 90 mcg

Carlson
<p>The formula provides 90 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Performance

Vitamin K2 as MK-7 100 mcg

Healthy Origins
<p>The formula provides 100 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
88 Budget

Vitamin K2 MK-7 100 mcg

Nutricost
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K (Menaquinone-7), making it a practical budget alternative to the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Budget

MK-7 Vitamin K-2 100 mcg

NOW
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K2 (Menaquinone-7), making it a practical budget alternative to the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
85 Budget

Vitamin K2 MenaQ7 100 mcg

AN Amazing Nutrition Amazing Formulas
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K2 (Natto), making it a practical budget alternative to the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Value

Vitamins D3 2500 IU (62.5 mcg) & K2 120 mcg

NaturesPlus
<p>The formula combines 120 mcg of Vitamin K2 (Menaquinone-7) and 62.50 mcg of Vitamin D3 (Cholecalciferol) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Value

MK-7 Vitamin K-2 100 mcg

NOW
<p>The formula combines 100 mcg of Vitamin K-2 (Menaquinone-7) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Value

Vitamin K2 100 mcg + Vitamin D3 125 mcg

Nutricost
<p>The formula combines 100 mcg of Vitamin K (Menaquinone-7) and 125 mcg of Vitamin D (Cholecalciferol) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 90 mcg of Vitamin K2 (Menaquinone-7), 50 mcg of Vitamin D (Cholecalciferol), and 1 Gram(s) of Norwegian Fish Oil concentrate. The high vitamin D amount warrants attention to total intake, and vitamin K may interfere with warfarin-type anticoagulants.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Association of vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis.
    Chen HG; Sheng LT; Zhang YB; Cao AL; Lai YW; Kunutsor SK; Jiang L; Pan A · European journal of nutrition · 2020
    Meta-analysis222,592 participants21 studies pooledHeart Health forVitamin K
  2. Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.
    Tanaka S; Miyazaki T; Uemura Y; Miyakawa N; Gorai I; Nakamura T; Fukunaga M; Ohashi Y; Ohta H; Mori S; Hagino H; Hosoi T; Sugimoto T; Itoi E; Orimo H; Shiraki M · Journal of bone and mineral metabolism · 2018
    Randomized trial1,874 participantsBone Health forVitamin K
  3. Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.
    Witham MD; Lees JS; White M; Band M; Bell S; Chantler DJ; Ford I; Fulton RL; Kennedy G; Littleford RC; McCrea IV; McGlynn D; Panarelli M; Ralston MR; Rutherford E; Severn A; Thomson N; Traynor JP; Struthers AD; Wetherall K; Mark PB · Journal of the American Society of Nephrology : JASN · 2021
    Randomized trial159 participantsHeart Health forVitamin K
  4. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  5. Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women.
    Kristensen M; Kudsk J; Bügel S · European journal of nutrition · 2008
    Randomized trial31 participantsHeart Health forVitamin K
  6. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R · PLoS medicine · 2009
    Randomized trial440 participantsBone Health forVitamin K
  7. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsHeart Health Cardiovascular Support forVitamin K
  8. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  9. Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials.
    Vlasschaert C; Goss CJ; Pilkey NG; McKeown S; Holden RM · Nutrients · 2021
    Systematic review9 studies pooledHeart Health forVitamin K
  10. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Meta-analysis6,759 participants19 studies pooledBone Health forVitamin K
  11. Vitamin K intake and all-cause and cause specific mortality.
    Zwakenberg SR; den Braver NR; Engelen AIP; Feskens EJM; Vermeer C; Boer JMA; Verschuren WMM; van der Schouw YT; Beulens JWJ · Clinical nutrition (Edinburgh, Scotland) · 2018
    Cohort study33,289 participantsHeart Health forVitamin K
  12. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  13. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  14. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsHeart Health Cardiovascular Support forVitamin K
  15. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women.
    Rønn SH; Harsløf T; Pedersen SB; Langdahl BL · European journal of endocrinology · 2017
    Randomized trial148 participantsBone Health forVitamin K
  16. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsHeart Health Cardiovascular Support forVitamin K
  17. Dietary vitamin K intakes and atherosclerotic cardiovascular disease incidence: Findings from the UK biobank.
    Dupuy M; Li C; Pokharel P; Zhong L; Parmenter BH; Radavelli-Bagatini S; Dalla Via J; Linneberg A; Jakobsen J; Kühn T; Cassidy A; Hodgson JM; Lewis JR; Sim M; Bondonno NP · Atherosclerosis · 2026
    Cohort study112,111 participantsHeart Health forVitamin K
  18. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women.
    Bolton-Smith C; McMurdo ME; Paterson CR; Mole PA; Harvey JM; Fenton ST; Prynne CJ; Mishra GD; Shearer MJ · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2007
    Randomized trial244 participantsBone Health forVitamin K
  19. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  20. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K
  21. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  22. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  23. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  24. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  25. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  26. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  27. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  28. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  29. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  30. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsHeart Health forVitamin D
  31. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  32. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  33. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisHeart Health forVitamin D